{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:58:53Z","timestamp":1794751133831,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interferon lambda-2 (IL28A) has a wide antiviral effect with fewer side-effects. Autophagy is a host mechanism to maintain intracellular homeostasis and defends invasion of pathogenic microorganisms. HCV NS5A can disable host defense systems to support HCV replication. Thus, molecular mechanism of interaction among interferon lambda, autophagy, and HCV was concerned and explored in this study. We report that HCV NS5A activated an incomplete autophagy by promoting the autophagic ubiquitylation-like enzymes ATG3, ATG5, ATG7, ATG10, and autophagosome maker LC3B, but blocked autophagy flux; IL28A bound to NS5A at NS5A-ISDR region, and degraded HCV-NS5A by promoting autolysosome formations in HepG2 cells. A software prediction of IL28A protein conformation indicated a potential structure of IL28A homotetramer; the first \u03b1-helix of IL28A locates in the interfaces among the four IL28A chains to maintain IL28A homotetrameric conformation. Co-IP and cell immunofluorescence experiments with sequential deletion mutants demonstrate that IL28A preferred a homotetramer conformation to a monomer in the cells; the IL28A homotetramer is positively correlated with autolysosomal degradation of HCV NS5A and the other HCV proteins. Summarily, the first \u03b1-helix of IL28A protein is the key domain for maintaining IL28A homotetramer which is required for promoting formation of autolysosomes and degradation of HCV proteins in vitro.<\/jats:p>","DOI":"10.1038\/s41419-020-2400-9","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T14:02:16Z","timestamp":1584972136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["IL28A protein homotetramer structure is required for autolysosomal degradation of HCV-NS5A in vitro"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3365-1451","authenticated-orcid":false,"given":"Yuan-yuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-gen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"2400_CR1","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/17425255.2016.1209484","volume":"12","author":"I Esposito","year":"2016","unstructured":"Esposito, I., Trinks, J. & Soriano, V. Hepatitis C virus resistance to the new direct-acting antivirals. Expert Opin. drug Metab. Toxicol. 12, 1197\u20131209 (2016).","journal-title":"Expert Opin. drug Metab. Toxicol."},{"key":"2400_CR2","first-page":"76","volume":"62","author":"C Premoli","year":"2016","unstructured":"Premoli, C. & Aghemo, A. Directly acting antivirals against hepatitis C virus: mechanisms of action and impact of resistant associated variants. Minerva Gastroenterol. Dietol. 62, 76\u201387 (2016).","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"2400_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jhep.2013.03.030","volume":"59","author":"JM Pawlotsky","year":"2013","unstructured":"Pawlotsky, J. M. NS5A inhibitors in the treatment of hepatitis C. J. Hepatol. 59, 375\u2013382 (2013).","journal-title":"J. Hepatol."},{"key":"2400_CR4","doi-asserted-by":"publisher","first-page":"e0122844","DOI":"10.1371\/journal.pone.0122844","volume":"10","author":"HJ Kwon","year":"2015","unstructured":"Kwon, H. J. et al. Direct binding of ledipasvir to HCV NS5A: mechanism of resistance to an HCV antiviral agent. PLoS ONE 10, e0122844 (2015).","journal-title":"PLoS ONE"},{"key":"2400_CR5","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.3748\/wjg.v20.i11.2902","volume":"20","author":"S Nakamoto","year":"2014","unstructured":"Nakamoto, S., Kanda, T., Wu, S., Shirasawa, H. & Yokosuka, O. Hepatitis C virus NS5A inhibitors and drug resistance mutations. World J. Gastroenterol. 20, 2902\u20132912 (2014).","journal-title":"World J. Gastroenterol."},{"key":"2400_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cytogfr.2014.07.015","volume":"25","author":"FC Lin","year":"2014","unstructured":"Lin, F. C. & Young, H. A. Interferons: success in anti-viral immunotherapy. Cytokine Growth Factor Rev. 25, 369\u2013376 (2014).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2400_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.coi.2011.07.007","volume":"23","author":"SVIFN-lambdas Kotenko","year":"2011","unstructured":"Kotenko, S. V. I. F. N.-lambdas Curr. Opin. Immunol. 23, 583\u2013590 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"2400_CR8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/hep.23816","volume":"52","author":"M Buti","year":"2010","unstructured":"Buti, M. et al. Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response. Hepatology 52, 1201\u20131207 (2010).","journal-title":"Hepatology"},{"key":"2400_CR9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ni.3212","volume":"16","author":"A Wack","year":"2015","unstructured":"Wack, A., Terczynska-Dyla, E. & Hartmann, R. Guarding the frontiers: the biology of type III interferons. Nat. Immunol. 16, 802\u2013809 (2015).","journal-title":"Nat. Immunol."},{"key":"2400_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.15252\/emmm.201606413","volume":"8","author":"S Davidson","year":"2016","unstructured":"Davidson, S. et al. IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment. EMBO Mol. Med. 8, 1099\u20131112 (2016).","journal-title":"EMBO Mol. Med."},{"key":"2400_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-15774-0_1","volume":"850","author":"IE Galani","year":"2015","unstructured":"Galani, I. E., Koltsida, O. & Andreakos, E. Type III interferons (IFNs): emerging master regulators of immunity. Adv. Exp. Med. Biol. 850, 1\u201315 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2400_CR12","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","volume":"79","author":"MD Robek","year":"2005","unstructured":"Robek, M. D., Boyd, B. S. & Chisari, F. V. Lambda interferon inhibits hepatitis B and C virus replication. J. Virol. 79, 3851\u20133854 (2005).","journal-title":"J. Virol."},{"key":"2400_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/35056522","volume":"2","author":"Y Ohsumi","year":"2001","unstructured":"Ohsumi, Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat. Rev. Mol. cell Biol. 2, 211\u2013216, https:\/\/doi.org\/10.1038\/35056522 (2001).","journal-title":"Nat. Rev. Mol. cell Biol."},{"key":"2400_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2016.11.002","volume":"385","author":"YK Jo","year":"2017","unstructured":"Jo, Y. K. et al. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells. Cancer Lett. 385, 21\u201327 (2017).","journal-title":"Cancer Lett."},{"key":"2400_CR15","first-page":"169","volume":"335","author":"V Deretic","year":"2009","unstructured":"Deretic, V. et al. Autophagy in immunity against mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy. Curr. Top. Microbiol. Immunol. 335, 169\u2013188 (2009).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2400_CR16","doi-asserted-by":"publisher","unstructured":"Kuo, S. M. et al. Inhibition of avian influenza A virus replication in human cells by host restriction factor TUFM is correlated with autophagy. mBio 8, https:\/\/doi.org\/10.1128\/mBio.00481-17 (2017).","DOI":"10.1128\/mBio.00481-17"},{"key":"2400_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/joim.12596","volume":"281","author":"R Nardacci","year":"2017","unstructured":"Nardacci, R. et al. Role of autophagy in HIV infection and pathogenesis. J. Intern. Med. 281, 422\u2013432, https:\/\/doi.org\/10.1111\/joim.12596 (2017).","journal-title":"J. Intern. Med."},{"key":"2400_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fcimb.2016.00174","volume":"6","author":"SM Pokharel","year":"2016","unstructured":"Pokharel, S. M., Shil, N. K. & Bose, S. Autophagy, TGF-beta, and SMAD-2\/3 signaling regulates interferon-beta response in respiratory syncytial virus Infected macrophages. Front. Cell. Infect. Microbiol. 6, 174 (2016).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2400_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2018.00362","volume":"8","author":"ML Pleet","year":"2018","unstructured":"Pleet, M. L. et al. Autophagy, EVs, and infections: a perfect question for a perfect time. Front. Cell. Infect. Microbiol. 8, 362 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2400_CR20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1083\/jcb.201002021","volume":"189","author":"T Saitoh","year":"2010","unstructured":"Saitoh, T. & Akira, S. Regulation of innate immune responses by autophagy-related proteins. J. Cell Biol. 189, 925\u2013935 (2010).","journal-title":"J. Cell Biol."},{"key":"2400_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/15548627.2017.1402992","volume":"14","author":"V Deretic","year":"2018","unstructured":"Deretic, V. & Levine, B. Autophagy balances inflammation in innate immunity. Autophagy 14, 243\u2013251 (2018).","journal-title":"Autophagy"},{"key":"2400_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.devcel.2014.06.013","volume":"30","author":"MA Mandell","year":"2014","unstructured":"Mandell, M. A. et al. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev. Cell 30, 394\u2013409 (2014).","journal-title":"Dev. Cell"},{"key":"2400_CR23","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1599207","volume":"21","author":"N Mizushima","year":"2007","unstructured":"Mizushima, N. Autophagy: process and function. Genes Dev. 21, 2861\u20132873 (2007).","journal-title":"Genes Dev."},{"key":"2400_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27\u201342 (2008).","journal-title":"Cell"},{"key":"2400_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1172\/JCI73941","volume":"125","author":"E White","year":"2015","unstructured":"White, E. The role for autophagy in cancer. J. Clin. Investig. 125, 42\u201346 (2015).","journal-title":"J. Clin. Investig."},{"key":"2400_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature06639","volume":"451","author":"N Mizushima","year":"2008","unstructured":"Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069\u20131075 (2008).","journal-title":"Nature"},{"key":"2400_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1515\/hsz-2015-0172","volume":"396","author":"L Wang","year":"2015","unstructured":"Wang, L. & Ou, J. H. Hepatitis C virus and autophagy. Biol. Chem. 396, 1215\u20131222 (2015).","journal-title":"Biol. Chem."},{"key":"2400_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/hep.22464","volume":"48","author":"D Sir","year":"2008","unstructured":"Sir, D. et al. Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology 48, 1054\u20131061 (2008).","journal-title":"Hepatology"},{"key":"2400_CR29","doi-asserted-by":"publisher","first-page":"e0122109","DOI":"10.1371\/journal.pone.0122109","volume":"10","author":"Y Shi","year":"2015","unstructured":"Shi, Y. et al. Coxsackievirus A16 elicits incomplete autophagy involving the mTOR and ERK pathways. PLoS ONE 10, e0122109 (2015).","journal-title":"PLoS ONE"},{"key":"2400_CR30","doi-asserted-by":"publisher","first-page":"13185","DOI":"10.1128\/JVI.06099-11","volume":"85","author":"S Taguwa","year":"2011","unstructured":"Taguwa, S. et al. Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus. J. Virol. 85, 13185\u201313194 (2011).","journal-title":"J. Virol."},{"key":"2400_CR31","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1080\/15548627.2018.1466014","volume":"14","author":"L Zhang","year":"2018","unstructured":"Zhang, L., Qin, Y. & Chen, M. Viral strategies for triggering and manipulating mitophagy. Autophagy 14, 1665\u20131673 (2018).","journal-title":"Autophagy"},{"key":"2400_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3233\/JAD-2012-112000","volume":"30","author":"S Santana","year":"2012","unstructured":"Santana, S., Bullido, M. J., Recuero, M., Valdivieso, F. & Aldudo, J. Herpes simplex virus type I induces an incomplete autophagic response in human neuroblastoma cells. J. Alzheimer\u2019s Dis. 30, 815\u2013831 (2012).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"2400_CR33","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1099\/vir.0.009332-0","volume":"90","author":"M Hughes","year":"2009","unstructured":"Hughes, M., Griffin, S. & Harris, M. Domain III of NS5A contributes to both RNA replication and assembly of hepatitis C virus particles. J. Gen. Virol. 90, 1329\u20131334 (2009).","journal-title":"J. Gen. Virol."},{"key":"2400_CR34","doi-asserted-by":"publisher","first-page":"e1007177","DOI":"10.1371\/journal.ppat.1007177","volume":"14","author":"S Shanmugam","year":"2018","unstructured":"Shanmugam, S., Nichols, A. K., Saravanabalaji, D., Welsch, C. & Yi, M. HCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A. PLoS Pathog. 14, e1007177 (2018).","journal-title":"PLoS Pathog."},{"key":"2400_CR35","doi-asserted-by":"publisher","unstructured":"Cevik, R. E. et al. Hepatitis C Virus NS5A targets nucleosome assembly protein NAP1L1 to control the innate cellular response. J. Virol. 91, https:\/\/doi.org\/10.1128\/JVI.00880-17 (2017).","DOI":"10.1128\/JVI.00880-17"},{"key":"2400_CR36","doi-asserted-by":"publisher","unstructured":"Kim, J. Y., Wang, L., Lee, J. & Ou, J. J. Hepatitis C virus induces the localization of lipid rafts to autophagosomes for Its RNA replication. J. Virol. 91, https:\/\/doi.org\/10.1128\/JVI.00541-17 (2017).","DOI":"10.1128\/JVI.00541-17"},{"key":"2400_CR37","doi-asserted-by":"publisher","first-page":"18036","DOI":"10.1074\/jbc.M111.320085","volume":"287","author":"D Sir","year":"2012","unstructured":"Sir, D. et al. Replication of hepatitis C virus RNA on autophagosomal membranes. J. Biol. Chem. 287, 18036\u201318043 (2012).","journal-title":"J. Biol. Chem."},{"key":"2400_CR38","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1111\/j.1365-2893.2010.01379.x","volume":"18","author":"K Kumthip","year":"2011","unstructured":"Kumthip, K. et al. Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy. J. Viral Hepat. 18, e117\u2013e125 (2011).","journal-title":"J. Viral Hepat."},{"key":"2400_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11105-3","volume":"7","author":"Q Zhao","year":"2017","unstructured":"Zhao, Q. et al. Dual roles of two isoforms of autophagy-related gene ATG10 in HCV-subgenomic replicon mediated autophagy flux and innate immunity. Sci. Rep. 7, 11250 (2017).","journal-title":"Sci. Rep."},{"key":"2400_CR40","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3389\/fimmu.2018.02176","volume":"9","author":"MQ Zhang","year":"2018","unstructured":"Zhang, M. Q., Li, J. R., Peng, Z. G. & Zhang, J. P. Differential effects of autophagy-related 10 protein on HCV replication and autophagy flux are mediated by its cysteine(44) and cysteine(135). Front. Immunol. 9, 2176 (2018).","journal-title":"Front. Immunol."},{"key":"2400_CR41","doi-asserted-by":"publisher","first-page":"D297","DOI":"10.1093\/nar\/gkt1208","volume":"42","author":"T Madej","year":"2014","unstructured":"Madej, T. et al. MMDB and VAST+: tracking structural similarities between macromolecular complexes. Nucleic Acids Res. 42, D297\u2013D303 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR42","doi-asserted-by":"publisher","first-page":"8130","DOI":"10.1074\/jbc.M111289200","volume":"277","author":"V Brass","year":"2002","unstructured":"Brass, V. et al. An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J. Biol. Chem. 277, 8130\u20138139 (2002).","journal-title":"J. Biol. Chem."},{"key":"2400_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10631","volume":"7","author":"N Kim","year":"2016","unstructured":"Kim, N. et al. Interferon-inducible protein SCOTIN interferes with HCV replication through the autolysosomal degradation of NS5A. Nat. Commun. 7, 10631 (2016).","journal-title":"Nat. Commun."},{"key":"2400_CR44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2893.2006.00739.x","volume":"13","author":"T Kohashi","year":"2006","unstructured":"Kohashi, T. et al. Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication. J. Viral Hepat. 13, 582\u2013590 (2006).","journal-title":"J. Viral Hepat."},{"key":"2400_CR45","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/hep.23766","volume":"52","author":"ZG Peng","year":"2010","unstructured":"Peng, Z. G. et al. Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA. Hepatology 52, 845\u2013853 (2010).","journal-title":"Hepatology"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2400-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:51:07Z","timestamp":1670251867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2400-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["2400"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2400-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"200"}}